GlassScriptPhysician profile
Sydney Grabau
NPI 1013323740
$14,209.45
in general payments reported to CMS, 2019-2025
55 companies · $2,482 in 2025
The $2,482 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,855 · 2022: $2,315 · 2023: $2,346 · 2024: $3,212 · 2025: $2,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,985 · Education: $55.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,984.77 |
| Education | $55.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,314.39 | 2021-2025 | |
| Amgen INC. | $1,442.05 | 2021-2024 | Aimovig, Uplizna |
| Mdd US Operations, LLC | $1,297.35 | 2021-2025 | Gocovri, Apokyn, Gocovri |
| Ucb, INC. | $1,295.54 | 2021-2025 | Nayzilam, Rystiggo, Fintepla |
| Teva Pharmaceuticals USA, INC. | $670.95 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Jazz Pharmaceuticals INC. | $611.04 | 2021-2025 | |
| Avanir Pharmaceuticals, INC. | $573.35 | 2021-2022 | |
| Lilly USA, LLC | $529.26 | 2021-2025 | Emgality, Reyvow, Zepbound |
| Livanova USA, INC. | $513.70 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $424.13 | 2021-2025 | Valtoco |
| Currax Pharmaceuticals LLC | $375.12 | 2021-2024 | Onzetra Xsail |
| Tonix Medicines, INC. | $324.17 | 2024-2025 | Zembrace Symtouch |
| Sk Life Science, INC. | $305.67 | 2022-2025 | Xcopri |
| Impel Pharmaceuticals INC. | $273.00 | 2022-2023 | Trudhesa |
| Lundbeck LLC | $246.48 | 2021-2025 | Vyepti, Rexulti |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Grabau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.